Skip to content
2000
Volume 27, Issue 10
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

As a member of the AF4/FMR2 (AFF) family, AFF4 is a scaffold protein in the superelongation complex (SEC). In this mini-view, we discuss the role of AFF4 as a transcription elongation factor that mediates HIV activation and replication and stem cell osteogenic differentiation. AFF4 also promotes the progression of head and neck squamous cell carcinoma, leukemia, breast cancer, bladder cancer and other malignant tumors. The biological function of AFF4 is largely achieved through SEC assembly, regulates SRY-box transcription factor 2 (SOX2), MYC, estrogen receptor alpha (ESR1), inhibitor of differentiation 1 (ID1), c-Jun and noncanonical nuclear factor-ΚB (NF-ΚB) transcription and combines with fusion in sarcoma (FUS), unique regulatory cyclins (CycT1), or mixed lineage leukemia (MLL). We explore the prospects of using AFF4 as a therapeutic in Acquired immunodeficiency syndrome (AIDS) and malignant tumors and its potential as a stemness regulator.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073241079230920082056
2024-06-01
2025-07-03
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/0113862073241079230920082056
Loading

  • Article Type:
    Review Article
Keyword(s): AFF4; osteogenic differentiation; SEC; transcription elongation; tumor; tumor progression
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test